The PTEN tumor suppressor acts as a phosphatase the levels of p27 KIP1 . To efficiently express PTEN and examine its cell cycle effects, we have reintroduced the for phosphatidylinositol-3,4,5-trisphosphate (PIP3) [1, 2] . We have shown previously that PTEN Pten gene into a PTEN-deficient human glioblastoma cell line, U87MG, by using recombinant retroviruses [3] .
To determine whether SKP2 is a critical target for the PTEN pathway that regulates p27 KIP1 levels, we tested whether expression of SKP2 in U87 cells is sufficient to restore p27 levels when PTEN is present. As shown in
Results and discussion
To determine how PTEN regulates cell cycle progression, Figure 2a , while PTEN induced high levels of p27, expression of SKP2 together with PTEN completely supwe investigated the mechanism by which PTEN controls Figure 2b ). This result suggests that cyclin E itself, in the absence of SKP2, is not sufficient to trigger the other hand, Akt phosphorylation was still inhibited by PTEN, either in the presence or absence of SKP2, and degradation of p27. Expression of CDK2 also failed to rescue the p27 downregulation defect in the PTENthis finding suggests that PIP3 levels remained low. It has been shown that cyclin E/CDK2 can phosphorylate expressing cells (data not shown). In addition, expression of cyclin E or CDK2 did not further enhance the p27 on threonine 187 (Thr 187) [10, 11] , and the Thr 187 phosphorylation is essential for the subsequent degradaeffect of SKP2 on the downregulation of p27 (Figure 2a) . The observation that SKP2, but not cyclin E or CDK2, tion of p27 [5-7, 10, 11] . In PTEN-expressing cells, p27 accumulation led to the inhibition of cyclin E-associated can reverse the effect of PTEN on p27 accumulation suggests that SKP2 is a rate-limiting factor in p27 ubiquitikinase activity (see below and Figure 2b ), while the protein level of cyclin E was not affected by PTEN expresnation and degradation and that PTEN regulates this process. sion (Figure 1a) . We found that ectopic expression of cyclin E failed to downregulate p27 in PTEN-expressing U87 cells (Figure 2a) , although the expressed cyclin E It is established that the critical function of p27 KIP1 in the late G1 phase of the cell cycle is to inhibit the kinase resulted in the restoration of the cyclin E/CDK2 kinase activity that was originally inhibited by PTEN (see below activity of cyclin E/CDK2 and thus to prevent premature -mediated p27 degradation is dependent on the presence of phosphorylated mediated rescue of p27 degradation in PTEN-expressing cells is sufficient to restore the cyclin E/CDK2 kinase Thr 187 in p27 and that cyclin E/CDK2 can phosphorylate Thr 187 in p27 [5-7, 10, 11] . Our finding that SKP2 activity. Indeed, while PTEN expression led to the inhibition of cyclin E/CDK2 kinase activity, coexpression of expression alone is sufficient to rescue the p27 degradation defect in PTEN-expressing cells suggests that the SKP2 fully relieved such an inhibition (Figure 2b ). When cyclin E was coexpressed with PTEN, the cyclin E/CDK Thr 187 residue of p27 is still phosphorylated even when the kinase activity of cyclin E/CDK2 is inhibited. To kinase activity was higher than that in the vector control cells, as one would expect if the ectopically expressed examine the Thr 187 phosphorylation status of p27, we used an antibody that is specific for Thr 187-phoscyclin E were not completely inhibited by the endogenous p27 (Figure 2b ). When SKP2 and cyclin E were coexphorylated p27 [7] . To confirm the specificity of this antibody, we coexpressed cyclin E with PTEN. We reasoned pressed together with PTEN, a further increase of cyclin E/CDK2 kinase activity was observed, as compared with that under this condition, Thr 187-phosphorylated p27 should increase as a result of the restored cyclin E/CDK2 that of expressing SKP2 or cyclin E alone in the presence of PTEN (Figure 2b ). This result suggests that SKP2 can kinase activity (Figure 2b) . Indeed, we found that there was a higher level of the Thr 187-phosphorylated p27 further activate the cyclin E/CDK2 activity, likely through its effect on p27 degradation. In addition, SKP2 can simiwhen cyclin E was coexpressed with PTEN than when PTEN was expressed alone (Figure 2c ). Using this antilarly fully suppress p27 accumulation in cells treated with the PI 3-kinase inhibitor LY294002 and can recover cyclin body, we observed that in the PTEN-expressing cells, the levels of Thr 187-phosphorylated p27 were similar to E/CDK2 kinase activity in these cells (See Supplementary material, Figure S1 , available with this article on the inthose in the vector or the PTEN mutant controls ( Figure  2c ) even though cyclin E/CDK2 kinase activity was nearly ternet). The ability of SKP2 to fully rescue the cyclin E/CDK2 kinase activity in the PTEN-expressing cells or completely inhibited when PTEN was present (see Figure 2b) . These results raise the possibility that other ki-LY294002-treated cells suggests that SKP2-mediated p27 downregulation in these cells plays an important role in nase(s), in addition to cyclin E/CDK2, may be involved in the phosphorylation of p27. The steady-state levels of the activation of cyclin E/CDK2. Inhibition of PI 3-kinase affects p27 ubiquitination. Cell extracts were ubiquitin analogs ubiquitin aldehyde and methylated ubiquitin. Where prepared from actively growing U87-EcoR cells (control extract) or indicated, the purified recombinant cyclin E/CDK2 complex, the cells that had been treated with LY294002 for 24 hr (LY extract). SCF SKP2 complex, or the SKP2 protein itself were also added to the [ 35 S]p27 was incubated with the corresponding extracts at 30ЊC
reactions. The reaction products were immunoprecipitated with antifor 0 or 3 hr in the presence of ATP regeneration system and the p27 antibodies and were analyzed by SDS-PAGE and fluorography.
the phosphorylated p27 in cells are thus a combination of the activities of these kinases. To further determine the function of the endogenous SKP2 in the regulation of p27 in U87 cells, we expressed a dominant negative form of SKP2 (SKP2DN) that contains a deletion in the F box region known to be involved in the binding of SKP2 to the SKP1/Cul-1 complex [7] . Expression of SKP2DN in U87 cells led to accumulation of endogenous p27, while the levels of cyclin D were not affected (Figure 2d ). These results further strengthen the notion that downregulation of SKP2 levels by PTEN expression is mechanistically linked to the p27 accumulation in these cells.
To further investigate whether PTEN regulates the ubiquitin-dependent degradation of p27 through the SCF SKP2 complex, we examined the consequences of PI 3-kinase inhibition in an in vitro p27 ubiquitination assay [5] . As shown in Figure 3a , while the extracts prepared from actively growing U87 cells (control extract) readily ubiquitinated p27 in the presence of cyclin E/CDK2, the extracts component of the SCF SKP2 E3 ligase, to regulate the ubiquitin-dependent proteolysis of p27.
